Reply to “How to deconstruct ‘race’ and spirometry”

Nicole B. Ramsey; Andrea J. Apter; Elliot Israel; Margee M. Louisias; Lenora M. Noroski; Sharmilee M. Nyenhuis; Princess U. Ogbogu; Tamara T. Perry; Julie Wang; Carla M. Davis

doi:10.1016/j.jaip.2022.07.010

Reply to “How to deconstruct ‘race’ and spirometry”

Nicole B. Ramsey
, Andrea J. Apter
, Elliot Israel
, Margee M. Louisias
, Lenora M. Noroski
, Sharmilee M. Nyenhuis
, Princess U. Ogbogu
, Tamara T. Perry
, Julie Wang
, Carla M. Davis

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2489-2491
Number of pages	3
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	10
Issue number	9
DOIs	https://doi.org/10.1016/j.jaip.2022.07.010
State	Published - Sep 2022

Access to Document

10.1016/j.jaip.2022.07.010

Cite this

@article{5a41e5e464ae4e4eb33c03431ebcedda,

title = "Reply to “How to deconstruct {\textquoteleft}race{\textquoteright} and spirometry”",

author = "Ramsey, \{Nicole B.\} and Apter, \{Andrea J.\} and Elliot Israel and Louisias, \{Margee M.\} and Noroski, \{Lenora M.\} and Nyenhuis, \{Sharmilee M.\} and Ogbogu, \{Princess U.\} and Perry, \{Tamara T.\} and Julie Wang and Davis, \{Carla M.\}",

note = "Funding Information: Conflicts of interest: N.B. Ramsey receives grant support from National Institute of Environmental Health Sciences Award 1K12ES033594-01 and Pfizer Pharmaceuticals. A.J. Apter receives grant support from the Patient Centered Research Institute and is a consultant for UpToDate and an associate editor of the Journal of Allergy and Clinical Immunology. E. Israel is a Gloria and Anthony Simboli Distinguished Chair in Asthma Research; is a grantee from AstraZeneca, Avillion Mandala/Denali, Circassia, Gossamer Bio, the National Institutes of Health (NIH), Novartis, and the Patient Centered Research Institute; received royalties from UpToDate and Wolters Kluwer; received consulting fees from AB Science, Allergy and Asthma Network, Amgen, Arrowhead Pharmaceuticals, AstraZeneca, Avillion, Biometry, Equillium, Genentech, GlaxoSmithKline, Merck, the National Heart, Lung, and Blood Institute, Novartis, Pneuma Respiratory, PPS Health, Regeneron, Sanofi Genzyme, Sienna Biopharmaceuticals, TEVA, and Cowen; received honoraria from the Westchester Medical Center and the Yale School of Medicine; received payment for expert testimony from Cambridge Medical Experts, Danaher Lagnese, and SettlePou and for data and safety monitoring board participation from Novartis; has a leadership role in the National Asthma Education Prevention Program; has stock options at Vorso; and reports receipt of equipment or drug from Circassia, Genentech, and TEVA. M.M. Louisias is supported by the National Heart, Lung, and Blood Institute (Grant No. L30 HL143781); received a Brigham and Women's Hospital Minority Faculty Career Development Award; and is a consultant for RubiconMD. L.M. Noroski is a consultant/speaker for the Immunodeficiency Foundation. S.M. Nyenhuis receives grant support from the NIH (National Heart, Lung, and Blood Institute and National Institute of Environmental Health Sciences) and is an author for UpToDate and PRIME Education. P.U. Ogbogu is on the advisory board for AstraZeneca, GlaxoSmithKline, and Sanofi. T.T. Perry's research was funded by the NIH and the Arkansas Children's Research Institute. J. Wang received institutional research funding from the NIH/National Institute of Allergy and Infectious Diseases, Regeneron, DBV, and Aimmune; received consultancy fees from ALK Abello and Jubilant Hollister Stier; and is an author for UpToDate. C.M. Davis received research grant support from the NIH/National Institute of Allergy and Infectious Diseases (Consortium of Food Allergy Research/Consortium of Eosinophilic Gastrointestinal Researchers), DBV Technologies, Aimmune Therapeutics, Regeneron Pharmaceuticals, and the Scurlock Foundation; and is a consultant for Moonlight Therapeutics. Funding Information: Conflicts of interest: N.B. Ramsey receives grant support from National Institute of Environmental Health Sciences Award 1K12ES033594-01 and Pfizer Pharmaceuticals. A.J. Apter receives grant support from the Patient Centered Research Institute and is a consultant for UpToDate and an associate editor of the Journal of Allergy and Clinical Immunology. E. Israel is a Gloria and Anthony Simboli Distinguished Chair in Asthma Research; is a grantee from AstraZeneca, Avillion Mandala/Denali, Circassia, Gossamer Bio, the National Institutes of Health (NIH), Novartis, and the Patient Centered Research Institute; received royalties from UpToDate and Wolters Kluwer; received consulting fees from AB Science, Allergy and Asthma Network, Amgen, Arrowhead Pharmaceuticals, AstraZeneca, Avillion, Biometry, Equillium, Genentech, GlaxoSmithKline, Merck, the National Heart, Lung, and Blood Institute, Novartis, Pneuma Respiratory, PPS Health, Regeneron, Sanofi Genzyme, Sienna Biopharmaceuticals, TEVA, and Cowen; received honoraria from the Westchester Medical Center and the Yale School of Medicine; received payment for expert testimony from Cambridge Medical Experts, Danaher Lagnese, and SettlePou and for data and safety monitoring board participation from Novartis; has a leadership role in the National Asthma Education Prevention Program; has stock options at Vorso; and reports receipt of equipment or drug from Circassia, Genentech, and TEVA. M.M. Louisias is supported by the National Heart, Lung, and Blood Institute (Grant No. L30 HL143781); received a Brigham and Women's Hospital Minority Faculty Career Development Award; and is a consultant for RubiconMD. L.M. Noroski is a consultant/speaker for the Immunodeficiency Foundation. S.M. Nyenhuis receives grant support from the NIH (National Heart, Lung, and Blood Institute and National Institute of Environmental Health Sciences) and is an author for UpToDate and PRIME Education. P.U. Ogbogu is on the advisory board for AstraZeneca, GlaxoSmithKline, and Sanofi. T.T. Perry{\textquoteright}s research was funded by the NIH and the Arkansas Children{\textquoteright}s Research Institute. J. Wang received institutional research funding from the NIH/National Institute of Allergy and Infectious Diseases, Regeneron, DBV, and Aimmune; received consultancy fees from ALK Abello and Jubilant Hollister Stier; and is an author for UpToDate. C.M. Davis received research grant support from the NIH/National Institute of Allergy and Infectious Diseases (Consortium of Food Allergy Research/Consortium of Eosinophilic Gastrointestinal Researchers), DBV Technologies, Aimmune Therapeutics, Regeneron Pharmaceuticals, and the Scurlock Foundation; and is a consultant for Moonlight Therapeutics. ",

year = "2022",

month = sep,

doi = "10.1016/j.jaip.2022.07.010",

language = "English",

volume = "10",

pages = "2489--2491",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "9",

}

TY - JOUR

T1 - Reply to “How to deconstruct ‘race’ and spirometry”

AU - Ramsey, Nicole B.

AU - Apter, Andrea J.

AU - Israel, Elliot

AU - Louisias, Margee M.

AU - Noroski, Lenora M.

AU - Nyenhuis, Sharmilee M.

AU - Ogbogu, Princess U.

AU - Perry, Tamara T.

AU - Wang, Julie

AU - Davis, Carla M.

N1 - Funding Information: Conflicts of interest: N.B. Ramsey receives grant support from National Institute of Environmental Health Sciences Award 1K12ES033594-01 and Pfizer Pharmaceuticals. A.J. Apter receives grant support from the Patient Centered Research Institute and is a consultant for UpToDate and an associate editor of the Journal of Allergy and Clinical Immunology. E. Israel is a Gloria and Anthony Simboli Distinguished Chair in Asthma Research; is a grantee from AstraZeneca, Avillion Mandala/Denali, Circassia, Gossamer Bio, the National Institutes of Health (NIH), Novartis, and the Patient Centered Research Institute; received royalties from UpToDate and Wolters Kluwer; received consulting fees from AB Science, Allergy and Asthma Network, Amgen, Arrowhead Pharmaceuticals, AstraZeneca, Avillion, Biometry, Equillium, Genentech, GlaxoSmithKline, Merck, the National Heart, Lung, and Blood Institute, Novartis, Pneuma Respiratory, PPS Health, Regeneron, Sanofi Genzyme, Sienna Biopharmaceuticals, TEVA, and Cowen; received honoraria from the Westchester Medical Center and the Yale School of Medicine; received payment for expert testimony from Cambridge Medical Experts, Danaher Lagnese, and SettlePou and for data and safety monitoring board participation from Novartis; has a leadership role in the National Asthma Education Prevention Program; has stock options at Vorso; and reports receipt of equipment or drug from Circassia, Genentech, and TEVA. M.M. Louisias is supported by the National Heart, Lung, and Blood Institute (Grant No. L30 HL143781); received a Brigham and Women's Hospital Minority Faculty Career Development Award; and is a consultant for RubiconMD. L.M. Noroski is a consultant/speaker for the Immunodeficiency Foundation. S.M. Nyenhuis receives grant support from the NIH (National Heart, Lung, and Blood Institute and National Institute of Environmental Health Sciences) and is an author for UpToDate and PRIME Education. P.U. Ogbogu is on the advisory board for AstraZeneca, GlaxoSmithKline, and Sanofi. T.T. Perry's research was funded by the NIH and the Arkansas Children's Research Institute. J. Wang received institutional research funding from the NIH/National Institute of Allergy and Infectious Diseases, Regeneron, DBV, and Aimmune; received consultancy fees from ALK Abello and Jubilant Hollister Stier; and is an author for UpToDate. C.M. Davis received research grant support from the NIH/National Institute of Allergy and Infectious Diseases (Consortium of Food Allergy Research/Consortium of Eosinophilic Gastrointestinal Researchers), DBV Technologies, Aimmune Therapeutics, Regeneron Pharmaceuticals, and the Scurlock Foundation; and is a consultant for Moonlight Therapeutics. Funding Information: Conflicts of interest: N.B. Ramsey receives grant support from National Institute of Environmental Health Sciences Award 1K12ES033594-01 and Pfizer Pharmaceuticals. A.J. Apter receives grant support from the Patient Centered Research Institute and is a consultant for UpToDate and an associate editor of the Journal of Allergy and Clinical Immunology. E. Israel is a Gloria and Anthony Simboli Distinguished Chair in Asthma Research; is a grantee from AstraZeneca, Avillion Mandala/Denali, Circassia, Gossamer Bio, the National Institutes of Health (NIH), Novartis, and the Patient Centered Research Institute; received royalties from UpToDate and Wolters Kluwer; received consulting fees from AB Science, Allergy and Asthma Network, Amgen, Arrowhead Pharmaceuticals, AstraZeneca, Avillion, Biometry, Equillium, Genentech, GlaxoSmithKline, Merck, the National Heart, Lung, and Blood Institute, Novartis, Pneuma Respiratory, PPS Health, Regeneron, Sanofi Genzyme, Sienna Biopharmaceuticals, TEVA, and Cowen; received honoraria from the Westchester Medical Center and the Yale School of Medicine; received payment for expert testimony from Cambridge Medical Experts, Danaher Lagnese, and SettlePou and for data and safety monitoring board participation from Novartis; has a leadership role in the National Asthma Education Prevention Program; has stock options at Vorso; and reports receipt of equipment or drug from Circassia, Genentech, and TEVA. M.M. Louisias is supported by the National Heart, Lung, and Blood Institute (Grant No. L30 HL143781); received a Brigham and Women's Hospital Minority Faculty Career Development Award; and is a consultant for RubiconMD. L.M. Noroski is a consultant/speaker for the Immunodeficiency Foundation. S.M. Nyenhuis receives grant support from the NIH (National Heart, Lung, and Blood Institute and National Institute of Environmental Health Sciences) and is an author for UpToDate and PRIME Education. P.U. Ogbogu is on the advisory board for AstraZeneca, GlaxoSmithKline, and Sanofi. T.T. Perry’s research was funded by the NIH and the Arkansas Children’s Research Institute. J. Wang received institutional research funding from the NIH/National Institute of Allergy and Infectious Diseases, Regeneron, DBV, and Aimmune; received consultancy fees from ALK Abello and Jubilant Hollister Stier; and is an author for UpToDate. C.M. Davis received research grant support from the NIH/National Institute of Allergy and Infectious Diseases (Consortium of Food Allergy Research/Consortium of Eosinophilic Gastrointestinal Researchers), DBV Technologies, Aimmune Therapeutics, Regeneron Pharmaceuticals, and the Scurlock Foundation; and is a consultant for Moonlight Therapeutics.

PY - 2022/9

Y1 - 2022/9

UR - https://www.scopus.com/pages/publications/85137012474

U2 - 10.1016/j.jaip.2022.07.010

DO - 10.1016/j.jaip.2022.07.010

M3 - Letter

C2 - 36087950

AN - SCOPUS:85137012474

SN - 2213-2198

VL - 10

SP - 2489

EP - 2491

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 9

ER -